Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis

Brain. 2024 Feb 1;147(2):554-565. doi: 10.1093/brain/awad404.

Abstract

Despite the overwhelming evidence that multiple sclerosis is an autoimmune disease, relatively little is known about the precise nature of the immune dysregulation underlying the development of the disease. Reasoning that the CSF from patients might be enriched for cells relevant in pathogenesis, we have completed a high-resolution single-cell analysis of 96 732 CSF cells collected from 33 patients with multiple sclerosis (n = 48 675) and 48 patients with other neurological diseases (n = 48 057). Completing comprehensive cell type annotation, we identified a rare population of CD8+ T cells, characterized by the upregulation of inhibitory receptors, increased in patients with multiple sclerosis. Applying a Multi-Omics Factor Analysis to these single-cell data further revealed that activity in pathways responsible for controlling inflammatory and type 1 interferon responses are altered in multiple sclerosis in both T cells and myeloid cells. We also undertook a systematic search for expression quantitative trait loci in the CSF cells. Of particular interest were two expression quantitative trait loci in CD8+ T cells that were fine mapped to multiple sclerosis susceptibility variants in the viral control genes ZC3HAV1 (rs10271373) and IFITM2 (rs1059091). Further analysis suggests that these associations likely reflect genetic effects on RNA splicing and cell-type specific gene expression respectively. Collectively, our study suggests that alterations in viral control mechanisms might be important in the development of multiple sclerosis.

Keywords: CSF; IFITM2; ZC3HAV1; eQTL; multiple sclerosis; scRNA-seq.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • CD8-Positive T-Lymphocytes
  • Cerebrospinal Fluid / metabolism
  • Humans
  • Membrane Proteins / genetics
  • Multiple Sclerosis*
  • Up-Regulation

Substances

  • Antiviral Agents
  • IFITM2 protein, human
  • Membrane Proteins